Sign inJoin waitlistJoin the waitlist

Yoshie Umemura

Director · Barrow Neurological Institute at St Joseph's Hospital and Medical Center

Credentials: · · · · ·

History

Neuro-Oncology Division · Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Present
Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Present
University of Arizona College of Medicine - Phoenix
Present

Memorial Sloan Kettering Cancer Center
2016–2017
Neurology
Dartmouth-Hitchcock Medical Center
2012–2016
University of Michigan, Clinical Research Design and Statistical Analysis
Saint George's University School of Medicine
2007–2011

Research

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
New England Journal of Medicine · 2023 · 643 citations
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Nature Communications · 2020 · 210 citations
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Journal of Neuro-Oncology · 2019 · 160 citations

DW
Daniel Wahl
10 papers
TL
Theodore Lawrence
9 papers
Wajd Al-Holou
9 papers · 7 as a resident
Jason Heth
7 papers
PW
Patrick Wen
7 papers
Denise Leung
5 papers
LJ
Larry Junck
5 papers
Timothy Cloughesy
5 papers
Ashley Sumrall
4 papers
Joe Mendez
4 papers
Oren Sagher
4 papers
TH
Todd Hollon
4 papers · 1 as a resident

Clinical trials

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Site PI · Recruiting · Phase 3
Nuvation Bio Inc.
2023–2030
A Study of NST-628 in Recurrent Grade 4 Glioma
Sub-investigator · Not yet recruiting · Early phase 1
Nader Sanai
2026–2028
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
Sub-investigator · Recruiting · Early phase 1
Nader Sanai
2026–2028